Prodhomme Mélanie K, Péricart Sarah, Pommier Roxane M, Morel Anne-Pierre, Brunac Anne-Cécile, Franchet Camille, Moyret-Lalle Caroline, Brousset Pierre, Puisieux Alain, Hoffmann Jean-Sébastien, Tissier Agnès
INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Centre of Lyon, Équipe Labellisée Ligue Contre le Cancer, Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France.
LabEx DEVweCAN, Université de Lyon, Lyon, France.
Front Cell Dev Biol. 2021 Aug 12;9:727429. doi: 10.3389/fcell.2021.727429. eCollection 2021.
Breast cancer cells frequently acquire mutations in faithful DNA repair genes, as exemplified by BRCA-deficiency. Moreover, overexpression of an inaccurate DNA repair pathway may also be at the origin of the genetic instability arising during the course of cancer progression. The specific gain in expression of , encoding the error-prone DNA polymerase Theta (POLθ) involved in theta-mediated end joining (TMEJ), is associated with a characteristic mutational signature. To gain insight into the mechanistic regulation of expression, this review briefly presents recent findings on the regulation of in the claudin-low breast tumor subtype, specifically expressing transcription factors involved in epithelial-to-mesenchymal transition (EMT) such as ZEB1 and displaying a paucity in genomic abnormality.
乳腺癌细胞经常在忠实的DNA修复基因中发生突变,BRCA缺陷就是一个例子。此外,不准确的DNA修复途径的过表达也可能是癌症进展过程中产生遗传不稳定性的根源。编码参与θ介导的末端连接(TMEJ)的易出错DNA聚合酶Theta(POLθ)的 的表达特异性增加,与一种特征性的突变特征相关。为了深入了解 表达的机制调控,本综述简要介绍了关于claudin-low乳腺肿瘤亚型中 调控的最新发现,该亚型特异性表达参与上皮-间质转化(EMT)的转录因子,如ZEB1,且基因组异常较少。